home / stock / hrtx / hrtx news


HRTX News and Press, Heron Therapeutics Inc. From 11/15/23

Stock Information

Company Name: Heron Therapeutics Inc.
Stock Symbol: HRTX
Market: NASDAQ
Website: herontx.com

Menu

HRTX HRTX Quote HRTX Short HRTX News HRTX Articles HRTX Message Board
Get HRTX Alerts

News, Short Squeeze, Breakout and More Instantly...

HRTX - Biotech Shares Up Sharply Following Quarterly Results

2023-11-15 12:35:40 ET A California-based %Biotech company is stealing the show so far during Wednesday’s session following yesterday’s earnings beat. According to some analysts, the company beat EPS by $0.14. Shares of %HeronTherapeutics (Nasdaq: HRTX) rallied str...

HRTX - 24/7 Market News Lunch Break 15 Nov 2023

2023-11-15 12:32:14 ET DENVER, Colo., Nov. 15, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Cormedix Inc (NASDAQ: CRMD), SciSparc Ltd (NASDAQ: SPRC), Solid Biosciences Inc (NASDAQ: SLDB), Heron ...

HRTX - Heron Therapeutics, Inc. (HRTX) Q3 2023 Earnings Call Transcript

2023-11-14 19:45:27 ET Heron Therapeutics, Inc. (HRTX) Q3 2023 Earnings Conference Call November 14, 2023 4:30 PM ET Company Participants Jeff Cohen - Executive Director, Assistant General Counsel and Assistant Secretary Craig Collard - Chief Executive Officer Ry...

HRTX - Heron Therapeutics GAAP EPS of -$0.17 beats by $0.14, revenue of $31.43M misses by $0.4M

2023-11-14 16:08:05 ET More on Heron Therapeutics Heron Therapeutics Q3 2023 Earnings Preview Seeking Alpha’s Quant Rating on Heron Therapeutics Historical earnings data for Heron Therapeutics Financial information for Heron Therapeutics For fu...

HRTX - Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance

Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance PR Newswire Heron is increasing full-year 2023 Net Product Sales guidance for the oncology care franchise to a range of $104 million to $106 million from a prior range of...

HRTX - Expected US Company Earnings on Tuesday, November 14th, 2023

Laser Photonics Corporation (LASE) is expected to report for Q2 2024 QuickLogic Corporation (QUIK) is expected to report $0.08 for Q3 2023 Stryve Foods Inc. (SNAX) is expected to report $-1.65 for Q3 2023 Reata Pharmaceuticals Inc. (RETA) is expected to report $-2.15 for Q3 2023 V...

HRTX - Expected earnings - Heron Therapeutics Inc.

Heron Therapeutics Inc. (HRTX) is expected to report $-0.31 for Q3 2023

HRTX - Heron Therapeutics to Report Third Quarter 2023 Financial Results On Tuesday, November 14, 2023

Heron Therapeutics to Report Third Quarter 2023 Financial Results On Tuesday, November 14, 2023 PR Newswire SAN DIEGO , Nov. 7, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives o...

HRTX - Appleseed Fund 2023 Annual Letter

2023-11-04 09:15:00 ET Summary Appleseed Fund was organized as a non-diversified series of Unified Series Trust with long-term capital appreciation as its investment objective. The Fund’s investment adviser is Pekin Singer Strauss Asset Management, Inc. Bond market returns ...

HRTX - Heron Therapeutics Inc. Commo $HRTX Technical Pivots with Risk Controls

2023-10-26 14:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Previous 10 Next 10